Versameb (private company)
See something wrong or missing? Let us know
Offices:Basel
Industry:BiotechHealth services
Business model:B2B
Versameb AG is a preclinical-stage biopharmaceutical company located in Basel, Switzerland and focusing on the development of novel RNA-based therapeutics. Versameb’s proprietary VERSagile technology platform enables efficient development of functional mRNA molecules in multiple disease areas with high unmet medical need including dermatology, oncology and myology.
values in USD
Investments 6.42M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Versameb
Name | Criteria | |
---|---|---|
![]() |
Abzena
42%
|
|
![]() |
Antag Therapeutics
42%
|
|
![]() |
Antelope Dx
42%
|
|
![]() |
Arthex Biotech S.L.
42%
|
|
![]() |
Cebiotex
42%
|
|
![]() |
Cell-Easy
42%
|
|
![]() |
CysBio
42%
|
|
![]() |
Eagle Genomics
42%
|
|
![]() |
Elypta
42%
|
|
![]() |
GeneMe
42%
|
|